N23375
yx72e10.s1 Soares melanocyte 2NbHM Homo sapiens cDNA clone IMAGE:267306 3' similar to gb:K00558 TUBULIN ALPHA-1 CHAIN (HUMAN), mRNA sequence.
460
mRNA
Homo sapiens
LX120991
JP 2017506877-A/23373: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct
HV879916
JP 2010507387-A/23327: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
DD549978
JP 2004508801-A/23375: NEISSERIAL ANTIGENIC PEPTIDES.
32
PRT
Neisseria
MC165219
JP 2019500349-A/23375: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
PA339023
JP 2021522188-A/23375: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation.
20
DNA
synthetic construct
HZ528156
JP 2016501039-A/23375: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
PA527859
JP 2022502046-A/10641: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct
DJ527175
JP 2010517930-A/23375: Method of constructing and screening libraries of peptide structures.
24
PRT
synthetic construct
OG752894
JP 2021120380-A/23375: CANCER NEOEPITOPES.
9
PRT
Homo sapiens
PD711289
JP 2021530475-A/23371: De novo Design of Protein Switches.
60
PRT
synthetic construct
DJ152755
JP 2007228956-A/23373: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
MD755617
JP 2019507579-A/23375: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY.
20
DNA
synthetic construct
LV569197
JP 2017029159-A/23375: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
FU797856
JP 2009528046-A/23373: Method for identifying useful proteins of brewery yeast.
25
DNA
Saccharomyces pastorianus
MC551875
JP 2019525738-A/23375: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES.
9
PRT
synthetic construct
MD269508
JP 2020517247-A/23375: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
DM797833
JP 2014068652-A/23375: NEISSERIAL ANTIGENIC PEPTIDES.
32
PRT
Neisseria
MC775485
JP 2018525446-A/23375: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
42
PRT
synthetic construct
PA394098
JP 2021533803-A/23181: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
DL032389
JP 2005512499-A/23375: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
957
DNA
synthetic construct
DL613977
JP 2011092200-A/23375: NEISSERIAL ANTIGENIC PEPTIDES.
32
PRT
Neisseria
LF830531
JP 2016528161-A/23364: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS.
18
RNA
synthetic construct
LF682596
JP 2016521556-A/23375: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
HW188403
JP 2013102767-A/23327: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
HW858599
JP 2015051004-A/23327: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
DL905119
JP 2014205669-A/23375: Method of constructing and screening libraries of peptide structures.
24
PRT
synthetic construct
DM760069
JP 2014079248-A/23375: NEISSERIAL ANTIGENIC PEPTIDES.
32
PRT
Neisseria
OG659761
JP 2021500321-A/23375: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES.
189
PRT
synthetic construct
LV771201
JP 2015523853-A/23375: COMPOSITIONS AND METHODS FOR MODULATING ATP2A2 EXPRESSION.
15
DNA
Homo sapiens